Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novo Nordisk presents new long-acting drug for growth hormone deficiency

June 28, 2012

Phase III study planned for MOD-4023

June 28, 2012

Bispecific tetravalent cancer immunotherapic is efficacious and safe in vivo

June 27, 2012

New Acceleron Pharma drug reduces anemia in model of myelodysplastic syndromes

June 27, 2012

CC-223 well tolerated in early-stage clinical study

June 27, 2012

Promising first-in-human results disclosed for CH-5132799

June 27, 2012

Mavoglurant studies reported at various conferences

June 27, 2012

Ongoing phase III rifampicin trial evaluates safety and efficacy in MSA

June 26, 2012

Significance of LMTK3 SNP explored in Japanese patients with gastric adenocarcinoma

June 26, 2012

New safety data from SMART trials disclosed at ongoing conference

June 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...